Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-12-29 CYTRX CORP 10% owner Sale −2,593,881 $2.20 $5.7M 0
2010-12-22 CYTRX CORP 10% owner Sale −500,000 $2.65 $1.3M 2,593,881
2010-06-30 CYTRX CORP 10% owner Sale −2,000,000 $2.55 $5.1M 3,093,881
2010-03-26 CYTRX CORP 10% owner Sale −675,000 $5.70 $3.8M 5,093,881
2009-09-23 CYTRX CORP 10% owner Sale −500,000 $2.50 $1.3M 5,768,881
2008-03-11 CYTRX CORP 10% owner Other disposition −4,526,624 6,296,575
2008-03-11 CYTRX CORP 10% owner Other disposition −27,694 6,268,881

Page 1 of 1 · 7 trades